Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · IEX Real-Time Price · USD
7.06
+0.06 (0.86%)
At close: Apr 17, 2024, 4:00 PM
6.90
-0.17 (-2.34%)
After-hours: Apr 17, 2024, 4:05 PM EDT
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $299.48 million as of April 17, 2024. Its market cap has increased by 18.89% in one year.
Market Cap
299.48M
Enterprise Value
275.44M
1-Year Change
18.89%
Ranking
Category
Stock Price
$7.06
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.60M to $299.48M, a decrease of -31.41%. That is a compound annual growth rate of -6.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 16, 2024 | 296.90M | 1.16% |
Apr 15, 2024 | 293.50M | 0.72% |
Apr 12, 2024 | 291.40M | -2.83% |
Apr 11, 2024 | 299.90M | -1.67% |
Apr 10, 2024 | 305.00M | 1.97% |
Apr 9, 2024 | 299.10M | 0.74% |
Apr 8, 2024 | 296.90M | 3.99% |
Apr 5, 2024 | 285.50M | 4.85% |
Apr 4, 2024 | 272.30M | 4.21% |
Apr 3, 2024 | 261.30M | 4.60% |
Apr 2, 2024 | 249.80M | -0.52% |
Apr 1, 2024 | 251.10M | - |
Mar 28, 2024 | 251.10M | 4.76% |
Mar 27, 2024 | 239.70M | 6.20% |
Mar 26, 2024 | 225.70M | 5.17% |
Mar 25, 2024 | 214.60M | 0.99% |
Mar 22, 2024 | 212.50M | -0.79% |
Mar 21, 2024 | 214.20M | 1.81% |
Mar 20, 2024 | 210.40M | 4.62% |
Mar 19, 2024 | 201.10M | -0.20% |
Mar 18, 2024 | 201.50M | -1.03% |
Mar 15, 2024 | 203.60M | -2.07% |
Mar 14, 2024 | 207.90M | -5.03% |
Mar 13, 2024 | 218.90M | -0.77% |
Mar 12, 2024 | 220.60M | -0.18% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
RAPT Therapeutics | 297.17M |
ChromaDex | 295.96M |
Opthea | 294.95M |
CorMedix | 294.89M |
Kamada | 294.27M |
Bioventus | 293.44M |
Procaps Group | 293.34M |
Akebia Therapeutics | 291.03M |